|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
FY2022
12 months to Oct 31, 2022
|
FY2021
12 months to Oct 31, 2021
|
|
|---|---|---|---|---|---|
| Sales | |||||
| Operating costs and expenses: | |||||
| Cost of sales | |||||
| Selling and administrative expenses | |||||
| Divestiture and related charges | |||||
| Total operating costs and expenses | |||||
| Operating profit | |||||
| Other income (expense): | |||||
| Interest expense | |||||
| Interest and investment income | |||||
| Pension settlement charge for U.S. Plans | |||||
| Other - net | |||||
| Total other income (expense) | |||||
| Income before income taxes | |||||
| Current | |||||
| Deferred | |||||
| Income tax expense | |||||
| Net income | |||||
| Average common shares (in shares) | |||||
| Incremental common shares attributable to outstanding stock options, restricted stock and deferred stock-based compensation (in shares) | |||||
| Average common shares and common share equivalents (in shares) | |||||
| Basic earnings per share (in dollars per share) | |||||
| Diluted earnings per share (in dollars per share) | |||||
| Dividends declared per common share (in dollars per share) |
Loading...